These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 12796139)
1. Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition. Tank J; Schroeder C; Diedrich A; Szczech E; Haertter S; Sharma AM; Luft FC; Jordan J Circulation; 2003 Jun; 107(23):2949-54. PubMed ID: 12796139 [TBL] [Abstract][Full Text] [Related]
2. Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects. Heusser K; Tank J; Diedrich A; Engeli S; Klaua S; Krüger N; Strauss A; Stoffels G; Luft FC; Jordan J Clin Pharmacol Ther; 2006 May; 79(5):500-8. PubMed ID: 16678551 [TBL] [Abstract][Full Text] [Related]
3. Alpha-2 adrenergic transmission and human baroreflex regulation. Tank J; Diedrich A; Szczech E; Luft FC; Jordan J Hypertension; 2004 May; 43(5):1035-41. PubMed ID: 15037555 [TBL] [Abstract][Full Text] [Related]
4. Yohimbine attenuates baroreflex-mediated bradycardia in humans. Tank J; Heusser K; Diedrich A; Brychta RJ; Luft FC; Jordan J Hypertension; 2007 Nov; 50(5):899-903. PubMed ID: 17875819 [TBL] [Abstract][Full Text] [Related]
5. Heart rate as a sympathetic marker during acute adrenergic challenge. Grassi G; Seravalle G; Bolla G; Quarti-Trevano F; Dell'Oro R; Arenare F; Mancia G J Hypertens; 2008 Jan; 26(1):70-5. PubMed ID: 18090542 [TBL] [Abstract][Full Text] [Related]
6. Baroreflex buffering and susceptibility to vasoactive drugs. Jordan J; Tank J; Shannon JR; Diedrich A; Lipp A; Schröder C; Arnold G; Sharma AM; Biaggioni I; Robertson D; Luft FC Circulation; 2002 Mar; 105(12):1459-64. PubMed ID: 11914255 [TBL] [Abstract][Full Text] [Related]
7. Acute effects of aldosterone on the autonomic nervous system and the baroreflex function in healthy humans. Heindl S; Holzschneider J; Hinz A; Sayk F; Fehm HL; Dodt C J Neuroendocrinol; 2006 Feb; 18(2):115-21. PubMed ID: 16420280 [TBL] [Abstract][Full Text] [Related]
8. Salt supresses baseline muscle sympathetic nerve activity in salt-sensitive and salt-resistant hypertensives. Abrahão SB; Tinucci T; Santello JL; Mion D J Hum Hypertens; 2002 Dec; 16(12):843-50. PubMed ID: 12522465 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of oral beta blockade on cardiovascular and sympathetic regulation. Beloka SP; Gouveia S; Gujic M; Naeije R; Rocha AP; van de Borne P J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):323-31. PubMed ID: 19903982 [TBL] [Abstract][Full Text] [Related]
10. Norepinephrine transporter inhibition alters the hemodynamic response to hypergravitation. Strempel S; Schroeder C; Hemmersbach R; Boese A; Tank J; Diedrich A; Heer M; Luft FC; Jordan J J Appl Physiol (1985); 2008 Mar; 104(3):756-60. PubMed ID: 18187607 [TBL] [Abstract][Full Text] [Related]
11. Pacemaker current inhibition in experimental human cardiac sympathetic activation: a double-blind, randomized, crossover study. Schroeder C; Heusser K; Zoerner AA; Großhennig A; Wenzel D; May M; Sweep FC; Mehling H; Luft FC; Tank J; Jordan J Clin Pharmacol Ther; 2014 Jun; 95(6):601-7. PubMed ID: 24509430 [TBL] [Abstract][Full Text] [Related]
12. α-Adrenergic effects on low-frequency oscillations in blood pressure and R-R intervals during sympathetic activation. Kiviniemi AM; Frances MF; Tiinanen S; Craen R; Rachinsky M; Petrella RJ; Seppänen T; Huikuri HV; Tulppo MP; Shoemaker JK Exp Physiol; 2011 Aug; 96(8):718-35. PubMed ID: 21602293 [TBL] [Abstract][Full Text] [Related]
13. Acute beta-blockade increases muscle sympathetic activity and modifies its frequency distribution. Cogliati C; Colombo S; Ruscone TG; Gruosso D; Porta A; Montano N; Malliani A; Furlan R Circulation; 2004 Nov; 110(18):2786-91. PubMed ID: 15505096 [TBL] [Abstract][Full Text] [Related]
14. Relating drug-induced changes in carotid artery mechanics to cardiovagal and sympathetic baroreflex control. O'Leary DD; Steinback CD; Cechetto AD; Foell BT; Topolovec JC; Gelb AW; Cechetto DF; Shoemaker JK Can J Physiol Pharmacol; 2005 May; 83(5):439-46. PubMed ID: 15897926 [TBL] [Abstract][Full Text] [Related]
16. Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Schroeder C; Tank J; Boschmann M; Diedrich A; Sharma AM; Biaggioni I; Luft FC; Jordan J Circulation; 2002 Jan; 105(3):347-53. PubMed ID: 11804991 [TBL] [Abstract][Full Text] [Related]
17. Baroreflex regulation of heart rate and sympathetic vasomotor tone in women and men. Tank J; Diedrich A; Szczech E; Luft FC; Jordan J Hypertension; 2005 Jun; 45(6):1159-64. PubMed ID: 15867130 [TBL] [Abstract][Full Text] [Related]
18. The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans. Hysek CM; Simmler LD; Ineichen M; Grouzmann E; Hoener MC; Brenneisen R; Huwyler J; Liechti ME Clin Pharmacol Ther; 2011 Aug; 90(2):246-55. PubMed ID: 21677639 [TBL] [Abstract][Full Text] [Related]
19. Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men. Christou DD; Jones PP; Jordan J; Diedrich A; Robertson D; Seals DR Circulation; 2005 Feb; 111(4):494-8. PubMed ID: 15687139 [TBL] [Abstract][Full Text] [Related]
20. Sympathetic cardiac influence and arterial blood pressure instability. Formes KJ; Wray DW; O-Yurvati AH; Weiss MS; Shi X Auton Neurosci; 2005 Mar; 118(1-2):116-24. PubMed ID: 15795185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]